Physician profile
Seth Plancher
NPI 1891721866
$2,547.19
in general payments reported to CMS, 2019-2025
22 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $186 · 2021: $784 · 2022: $474 · 2023: $153 · 2024: $386 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $491.26 | 2019-2023 | |
| Aspira Women'S Health INC | $312.66 | 2020-2022 | |
| Celularity INC. | $300.00 | 2021 | |
| Astellas Pharma US INC | $151.49 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $145.10 | 2024-2025 | Acessa Provu System, Novasure, Aptima |
| Evofem Biosciences, INC. | $140.05 | 2023-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $97.99 | 2020-2025 | Slynd |
| Scynexis, INC. | $97.52 | 2022 | |
| Sumitomo Pharma America, INC. | $93.58 | 2023-2025 | Myfembree |
| Biogen, INC. | $93.06 | 2025 | Zurzuvae |
| Amgen INC. | $83.25 | 2020-2024 | Prolia, Evenity |
| Merck Sharp & Dohme LLC | $79.34 | 2022-2024 | Gardasil, Gardasil 9 |
| Therapeuticsmd, INC. | $70.57 | 2019-2021 | |
| Pfizer INC. | $70.21 | 2019-2022 | |
| Agile Therapeutics, INC. | $69.02 | 2021-2024 | Twirla |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $58.71 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $56.52 | 2019-2020 | |
| Lupin INC. | $47.17 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $40.97 | 2025 | |
| Allergan, INC. | $19.54 | 2019 | |
| Myovant Sciences INC. | $17.60 | 2022 | |
| Organon LLC | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Plancher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.